Quantcast

Latest Cytochroma Stories

2011-07-26 11:00:00

MARKHAM, ON, July 26, 2011 /PRNewswire/ - Cytochroma today announced that it has closed an equity investment of $1 million from the Investment Accelerator Fund, a fund of the Province of Ontario that invests in emerging Ontario technology companies.  The investment is designed to advance and accelerate the Company's development of CTAP101 Capsules, a product currently in a Phase 2b study for the treatment of secondary hyperparathyroidism associated with vitamin D insufficiency in...

2011-06-13 07:00:00

MARKHAM, ON, June 13, 2011 /PRNewswire/ - Cytochroma today announced the appointment of Dr. Cynthia Lavoie and Mr. Osamu Otani to its Board of Directors. Dr. Lavoie replaced Dr. Luc Marengre as VG Partners' representative, and Mr. Otani replaced Dr. Seiichi Kiso as Mitsubishi Tanabe Pharma Corporation's representative on the Company's Board. The number of Board members remains unchanged at six members. "We are pleased to have Cynthia and Osamu join the Cytochroma Board. They bring...

2011-02-17 07:00:00

MARKHAM, ON, Feb. 17 /PRNewswire/ - Cytochroma today announced the initiation of a repeat-dose safety and efficacy study of CTAP101 Capsules in patients with vitamin D insufficiency, secondary hyperparathyroidism (SHPT) and stage 3 chronic kidney disease (CKD). "Vitamin D insufficiency in CKD patients is a significant problem associated with increased mortality and morbidity and for which no approved treatment is available," stated Joel Z. Melnick, M.D., Cytochroma's Vice President,...


Word of the Day
abrosia
  • Wasting away as a result of abstinence from food.
The word 'abrosia' comes from a Greek roots meaning 'not' and 'eating'.